In Brief: Ciba-Geigy Corp.
This article was originally published in The Tan Sheet
Executive Summary
Ciba-Geigy Corp.: Richard Barth is retiring as U.S. president and CEO on March 31, to be succeeded by Ciba Pharmaceuticals President Douglas Watson. Barth, a 30-year Ciba veteran, will retain the chairman's post, which he has held since 1990. Replacing Watson as president of the pharmaceuticals division will be Senior VP-Marketing James Callahan. Once the changes become effective, Remo Denti, the new head of Ciba's U.S. OTC business ("The Tan Sheet" May 5, p. 9), will report to Watson as well as Roland Genet, head of Ciba Self-Medications worldwide...